VICAL INC (73) | Uncategorized (9)
Recent Contracts
-
Rights Agreement, dated as of May 3, 2022, by and among Brickell Biotech, Inc., Brickell Subsidiary, Inc., and Bodor Laboratories, Inc
(Filed With SEC on May 3, 2022)
-
Description of the Registrants Securities Registered Pursuant to Section 12 of the Exchange Act
(Filed With SEC on March 15, 2022)
-
Description of the Registrants Securities Registered Pursuant to Section 12 of the Exchange Act
(Filed With SEC on March 9, 2021)
-
Letter Agreement, dated as of September 3, 2020, by and between Brickell Biotech, Inc. and Kaken Pharmaceutical Co., Ltd
(Filed With SEC on October 13, 2020)
-
(Filed With SEC on September 1, 2020)
-
Right of First Negotiation Agreement, as amended, dated March 31, 2015, by and between Brickell Biotech, Inc. and Kaken Pharmaceutical Co., Ltd
(Filed With SEC on September 3, 2019)
-
Brickell Biotech, Inc. Letter Agreement, dated July 10, 2018 by and between Brickell Biotech Inc. and Jose Breton
(Filed With SEC on September 3, 2019)
-
Form of Support Agreement, dated June 2, 2019, by and between the Company and each of the parties named in each agreement therein
(Filed With SEC on June 3, 2019)
-
Form of Lock-Up Agreement, dated June 2, 2019, by each of the parties named in each agreement therein
(Filed With SEC on June 3, 2019)